- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
InspireMD Inc (NSPR)
InspireMD Inc stock price live, this page displays NASDAQ NSPR stock exchange data. View the NSPR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the InspireMD Inc real time stock price chart below.
What Is the InspireMD Inc Stock Price Today?
The InspireMD Inc stock price today is 2.300.
What Is the Stock Symbol for InspireMD Inc?
The stock symbol for InspireMD Inc is ""NSPR.""
What Stock Exchange Does InspireMD Inc Trade On?
InspireMD Inc is listed and trades on the NASDAQ stock exchange.
Is InspireMD Inc a Good Stock to Buy?
Determining whether InspireMD Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NSPR quote. (ISIN: US45779A8466)
What Is the InspireMD Inc Stock Price Today?
The InspireMD Inc stock price today is 2.300.
What Is the Stock Symbol for InspireMD Inc?
The stock symbol for InspireMD Inc is ""NSPR.""
What Stock Exchange Does InspireMD Inc Trade On?
InspireMD Inc is listed and trades on the NASDAQ stock exchange.
Is InspireMD Inc a Good Stock to Buy?
Determining whether InspireMD Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NSPR quote. (ISIN: US45779A8466)
NASDAQ
Currency in USD
2.300
-0.050(-2.13%)
Closed·
After Hours
2.399+0.099(+4.304%)
·
Fair Value
An estimate of a InspireMD's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.290
2.400
52 wk Range
1.990
3.798
NSPR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
NSPR is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a InspireMD's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.2902.400
52 wk Range
1.9903.798
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NSPR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a InspireMD's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
4.500
Upside
+95.65%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K InspireMD Inc For: 9 July
- Investing.com
- Form 8K InspireMD Inc For: 13 June
- Investing.com
- Form 8K InspireMD Inc For: 9 July
- Investing.com
- Form 8K InspireMD Inc For: 24 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
InspireMD Inc Company Profile
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions. It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida.
InspireMD Inc Earnings Call Summary for Q1/2025
- InspireMD Q1 2025: EPS beat at -$0.22 vs -$0.31 forecast; revenue missed at $1.53M vs $1.79M expected; stock down 3.79% after-hours
- Revenue up 1.2% YoY; net loss of $11.166M; strong liquidity with current ratio of 5.28x; Financial Health Score at 2.18 (Fair)
- U.S. launch of CGuard Prime stent expected Q3 2025; FDA approval for CGuardians Two trial targeted H1 2026; Switchgard clearance late 2026
- CEO optimistic about CGuard Prime's potential in carotid disease treatment; clinical trial enrollment progressing well
- Risks: revenue shortfall, extended FDA timelines, ongoing net losses; analysts focused on approval delays and commercial strategy
Last Updated: 09/05/2025, 14:18
Read Full TranscriptCompare NSPR to Peers and Sector
Metrics to compare | NSPR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNSPRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.9x | −14.0x | −0.5x | |
PEG Ratio | 0.29 | 0.07 | 0.00 | |
Price/Book | 2.5x | 2.1x | 2.6x | |
Price / LTM Sales | 10.0x | 0.8x | 3.2x | |
Upside (Analyst Target) | 91.5% | 86.4% | 45.3% | |
Fair Value Upside | Unlock | 19.6% | 7.4% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.500
(+95.65% Upside)
Earnings
Latest Release
May 09, 2025
EPS / Forecast
-0.22 / -0.31
Revenue / Forecast
1.53M / 1.79M
People Also Watch
FAQ
What Stock Exchange Does InspireMD Trade On?
InspireMD is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for InspireMD?
The stock symbol for InspireMD is "NSPR."
What Is the InspireMD Market Cap?
As of today, InspireMD market cap is 70.77M.
What Is InspireMD's Earnings Per Share (TTM)?
The InspireMD EPS (TTM) is -0.79.
When Is the Next InspireMD Earnings Date?
InspireMD will release its next earnings report on 11 Aug 2025.
From a Technical Analysis Perspective, Is NSPR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has InspireMD Stock Split?
InspireMD has split 6 times.
How Many Employees Does InspireMD Have?
InspireMD has 66 employees.
What is the current trading status of InspireMD (NSPR)?
As of 16 Jul 2025, InspireMD (NSPR) is trading at a price of 2.30, with a previous close of 2.35. The stock has fluctuated within a day range of 2.29 to 2.40, while its 52-week range spans from 1.99 to 3.80.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.